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Summary.-The effect of exogenous sex hormones on the cell mediated response
in male and female mice has been studied by measuring the subcutaneous growth
of HeLa tumour nodules and the variation in the total lymphocyte count. It was
found that oestrogen treated male and female mice experienced a profound lympho-
penia which was vary rapid in onset. Concurrent with the lymphopenia there was
prolongation of HeLa tumour nodule growth in female mice, but not in males. A
lymphopenia occurred in androgen treated male mice with subsequent prolongation
of HeLa tumour nodule growth, and a lymphocytosis in female mice, with reduction
of HeLa tumour nodule growth.
THE CHANGES in lymphatic tissue
which result from the administration of
androgen and oestrogen in both normal
and surgically treated male and female
animals have been studied extensively.
Female hormones have been found to
induce acute involution of the thymus in
prepubertal rats (Golding and Ramirez,
1928; Carriere, Morel and Gineste, 1937;
Plagge, 1941; Money, Fager and Rawson,
1952) and in large doses oestrogen pro-
duces agranulocytosis and lymphopenia in
dogs (Dougherty, Wrilliams and Gardner,
1943). On the other hand, male hor-
mones have been found to produce
atrophy of the thymus in normal and
castrated animals (Andreasen, 1937; Chi-
odi, 1.938; Baez-Villasenor, Rath and
Finch, 1948) but it has been reported
that androgen administration has no
effect on the level of the peripheral blood
lymphocytes (Crafts, 1946).
In these investigations, the effect of
sex hormones on the total peripheral
lymphocyte count of mice was studied,
together with the ability of hormone
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treated mice to sustain the growth of
HeLa tumour nodules. The effect of
hormones when added in vitro to lympho-
cytes taken from normal male and female
mice was also studied.
MATERIALS AND METHODS
Mice. In order to reduce to a minimumn
the complications that, arose from using
mice inherently infected with bacteria,
viruses or helminths, the CBA strain bred
in the specific pathogen-free colony at the
National Institute for Medical Research was
used. Both male and female mice were
obtained at the prepubertal (before 7 weeks
of age) and postpubertal stages; 340 mice
were used, 10 in each experiment.
HeLa cells and measurement of tumour
size. The original HeLa cells were ob-
tained from t,he Central Public Health
Laboratories at Colindale, but thereafter the
stock of cells -was passaged in the laboratory.
They were shown to be free from mycoplasma.
The surface area of tumours that developed
in the mice was recorded by measuring 2
axes at rightangles using Vernier- callipers
and multiplying the lengths. Samples of
random tumours w%Nere examined histologic-
ally.
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subcutaneously as oestradiol benzoate (0 5
mg or 1 0 mg) and androgen w,as given
subcutaneously as testosterone phenylpro-
pionate (10 mg) either daily, starting at the
time when the HeLa cells were given, or
on the first 3-5 days and the last 3-5 days
of the average 2-week experimental period
when a peripheral lymphocyte count wvas
made.
Antilymphocyte serum.-Antilymphocyte
serum w%vas prepared by the method of
Levey and Medawar (1966) and wvas given
to 10 of the androgen treated female mice
under test. Each mouse received 0-25 ml
ofserum as a single subcutaneous injection.
Measurement of the effect of hormones on
lymniphocytes in vitro.-A modified trypan
blue dye exclusion test was used to study
the in vitro effect of androgen and oestrogen
on the lymphocytes from both male and
female mice. The lymphocytes were ob-
tained by making a suspension of the cells
in the thymus, removed by surgery, in the
manner reported by Levey and Medawar
(1966). The cell suspension obtained from
an individual mouse was suspended in
3 0 ml of Hanks' balanced salt solution
(to approximate to the total blood volume
of a mouse) and 0-25 mg of oestrogen or
0-6 mg of androgen, whichever was appro-
priate, was added to 1-5 ml ofthe lymphocyte
suspension. After gently shaking for 10 min
a small quantity of the treated lymphocytes
was removed and an equal volume of 0500
trypan blue was added. After 2 min the
killed lymphocytes had taken up the stain
and the proportion of stained (killed) to
total lymphocytes was counted in a chamber
under the microscope. The appropriate con-
trols (counting the number of dead lympho-
cytes in the untreated suspension) were
included in each test.
Measurement of lymphocyte counts in
mice.-The proportion of total lymphocytes
in whole blood was found by taking 10 mm3
of whole blood from the tail vein of the
inouse and adding this to 10 ml of white
cell diluent fluid containing 1% acetic acid
and 10% methyl violet. The resulting mix-
ture was then counted in an improved
Neubauer counting chamber. In all the
studies the count on Day 0 preceded hormone
administration. Each point in the figures
was the average count from 5 mice and no
individual count differed from the average
by more than 10%.
RESULTS
I. Effects of oestrogen administration on
the peripheral lymphocyte count
When female mice weregiven oestrogen
a profound lymphopenia occurred (78-
42%). When hormone administration
was stopped the lymphocyte count re-
turned to normal within 4 days in the
postpubertal female mice but further
doses of oestrogen resulted in a recurrence
of the lymphopenia (71-420o) (Fig. 1).
A similar effect could not be demonstrated
in the prepubertal female mice because
the repeated blood samples taken while
the mice were receiving oestrogen led to
the death of all the mice.
With male mice, however, both pre-
and postpubertal mice followed a similar
pattern. Oestrogen caused a lympho-
penia (80-33% in prepubertal males and
65-36% in postpubertal males) which
returned to normal in the absence of the
hormone, and a further lymphopenia
occurred when the hormone treatment
was restarted (75-37.5%O in prepubertal
males and 65-42% in postpubertal males)
(Fig. 2).
2. Effects of androgen administration on
the peripheral lymphocyte count
The effect of givinlg androgen was
different in the 2 sexes. In the female
postpubertal mice androgen gave rise to
a marked lymphocytosis (42-77%) which
was evident within 24 h. When treat-
ment was stopped there was a return
towards the original pretreatment levels,
which were low in this group of mice.
When the hormone was given again the
lymphocytosis recurred (48-70%). The
prepubertal female mice responded by
producing a lymphopenia (72-44%)o
which was followed by a lymphocytosis
(10-44%) when treatment was restarted
after the rest period. This finding was
unexpected, in view of the previous
results with the postpubertal females
(Fig. 3).
In the mice in which androgen had
stimulated a lymphocytosis, a single in-
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jection of ALS brought the levels of the
lymphocytes below the initial counts.
This effect was still pronounced on the
third day after giving ALS. Wrhen andro-
gen was given to male mice, however, the
picture was similar to that observed
when oestrogen was given to female
mice. Here in both pre- and postpubertal
mice a lymphopenia occurred (73-530%
in prepubertal males and 75-360 in
postpubertal males) which was relieved
by stopping the hormone treatment but a
further lymphopenia (60-420 in pre-
pubertal males and 45-220% in post-
pubertal males) was caused by giving
more hormone (Fig. 4). If male mice in
which androgen had caused a lympho-
penia were then given oestrogen before
being given further androgen, the lympho-
cytes in these animals behaved as if they
were from a female mouse in that a
lymphocytosis (13-320/) occurred. The
observed 19% rise in the total lymphocyte
count was similar to that obtained in
postpuibertal female mice retreated with
androgen. During the rest period, after
initial treatment with androgen, the rise
in the total lymphocyte count was only
70o in post pubertal male mice (Fig. 5).
3. Effects on the survival of HeLa tumours
WVhen both male and female mice
were given HeLa cells together with
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FIG. 4.-Effect of androgen on the total lymphocyte count in male mice.
prolonged administration of oestrogen
(which caused a lymphopenia), there
was an initial potentiation of growth of
the HeLa tumours, which was more
marked in the postpubertal mice (Fig. 6),
and the HeLa tumours survived longer
in the female mice than they did in the
males (20 and 19 days in the females
compared with 10 and 13 days in the
males). In fact, in the male mice the
nodules regressed as quickly as, or earlier
than, those in the control untreated mice.
Wrhen androgen was given to both pre-
and postpubertal female mice together
with HeLa cells the nodules which were
initially potentiated regressed earlier than
those in the untreated mice (12 days
compared with 13 days in the prepubertal
females and 13 days compared with 14
days in the postpubertal females (Fig. 7).
In both pre- and postpubertal male mice,
however, the HeLa nodules survived
longer than those in the untreated mice
(16 days compared with 13 days in the
prepubertal males and 17 days compared
with 14 days in the postpubertal males)
(Fig. 8).
When male mice receiving androgen
were pretreated with oestrogen (which in
normalmalemice also gave a lymphopenia)
a lymphocytosis occurred. This was simi-
lar to the reaction of a female mouse to
androgen. If these mice were given HeLa
cells the tumour nodules regressed quicker
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than those of the control mice (12 (lays
compared with 14 days) (Fig. 9), which
again resembled the reaction of a female
mouse when given androgen.
Histological analysis of randomly se-
lected tumour nodules confirmed the
presence of HeLa cells. However, these
(liffered from in vitro culture samples
because there was a marked reduction
in the volume of cytoplasm. This is
being investigated further.
4. Effects of hormones on lynmphocytes in
vitro
The effect of oestrogen and androgen
on the lymphocytes from male and female
mice showed that a high percentage of
lymphocytes were killed by the direct
action of oestrogen after only 10 minuLtes
contact (86% in males and 80% in
females). A similar highl kill occurred
when lymphocytes from inale mice were
treated with androgen (91%) but there
wA,as a very much reduced kill of the
lymphocytes from female mice when
treated1 with androgen (53oo) (Table).
TABLE. The in vitro Effect of Oestrogen
and Androqen on Lymphocytes from the
Thymuses of 4 M1lale and 4 Female
Mlice
(ont rols
( % kille(l)
Females 28- 2
AMales 331)
Oestr ogesi
( % kille(l)
79 .9
845
A nitdrogen
( killed)
153*)
91I (
I) C5us USIO5N
The results show it is possible to
alter the immune system of normal male
and female mice by giving them exogenous
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sex hormones, and that the effect is both
quantitative and qualitative. It has been
found, as has been shown in other species
of female animals (Dougherty et al.,
1943), that oestrogen depresses the total
lymphocyte count. A lymphopenia oc-
curs also in pre- and postpubertal male
mice treated with oestrogen. In view
of the rapidity of onset of the lympho-
penia following oestrogen therapy and
the rapid return to the initial counts
when treatment is stopped, it is suggested
that the lymphopenia is due to a direct
effect of oestrogen on the circulating
peripheral lymphocytes. This observa-
tion is borne out by the in vitro results.
Delaunay, Delaunay andLeBrun(1949)
haveshownthat lymphocytolysis occurs in
vitro and in vivo in response to adrenal
cortical extracts. In the present in vitro
investigations it has been shown that
oestrogen kills 80% and 85% of lympho-
cytes obtained from female and male
mice respectively, after only 10 min
contact. It may well be that a similar
mechanism is responsible for the in vivo
observations.
Prolonged oestrogen therapy in pre-
and postpubertal female mice enhances
initial HeLa tumour nodule growth, the
effect being more marked in the post-
pubertal mice. In addition, the tumour
nodules in the treated mice survive
longer than those in controls, suggesting
there may have been a depression of the
cell mediated response following oestrogen
administration. Mitchison (1955) impli-
cated this aspect of the immune system
as being the factor controlling allograft
survival. In studies of HeLa tumour
growth in mice treated with antilympho-
cyte serum it has been suggested that
the same mechanism plays some part in
xenograft survival (Franks, Curtis and
Perkins, 1973).
In male mice treated with oestrogen
there is a similar initial potentiation of
growth of the HeLa tumour nodule,
which is then followed by regression on
or before the nodule survival times in
control mice. Although a lymphopenia
has occurred, it is suggested that the
remaining thymus dependent lympho-
cytes have been stimulated to mount an
enhanced response. Only then can the
differences in the growth of HeLa cells
between treated male and female mice be
accounted for.
Androgen treatment of postpubertal
female mice resulted in a rapid lympho-
cytosis, which was evident within 24 h.
Although an unexpected lymphopenia
occurred initially in prepubertal female
mice, both produced a similar lympho-
cytosis when androgen treatment was
resumed after a rest period of 2 days.
When the mice were given antilymphocyte
serum, however, the observed rise in
the lymphocyte count was depressed
below the initial counts, indicating that
the lymphocytosis, in response to andro-
gen, may have involved primarily thymus
dependent cells. In view of the rapidity
of the lymphocytosis, it is suggested that
it is due to a direct action of androgen on
the thymus in female mice, potentiating
the release of T cells. In the in vitro
studies of the effects of androgen on
lymphocytes from female mice there was
a 23% rise in the number of killed cells
over the control counts. In the in vivo
state this loss of lymphocytes in response
to androgen was probably masked by the
overall lymphocytosis.
In the male mice, a profound and
lasting lymphopenia occurred when they
were treated with androgen. In vitro,
9100 of the lymphocytes were killed
within 10 min of adding the androgen.
This and the other in vitro results are in
agreement with the in vivo results. It is
interesting to note the differences in the
responses of males and females to andro-
gen both in vitro and in vivo. The
explanation for this is not clear, but it
may be due to some difference in the
cell membrane which prevents mass de-
struction of lymphocytes from females
and allows almost total destruction of
lymphocytes from males.
If postpubertal male mice are treated
with oestrogen before receiving further
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androgen, the androgen stimulates a
lymphocytosis. There is a 1900 rise
in the total lymphocyte count in the
2 days after retreatment with androgen
compared with 700 in a similar 2-day
period following initial treatment with
androgen. It is suggested this difference
in response to androgen, before and after
oestrogen, is due to the fact that male
mice pretreated with oestrogen appear
to behave like females, where a lympho-
cytosis also occurs in response to androgen.
When these mice are inoculated with
HeLa cells there is still an initial potentia-
tion of the tumour nodule growth, but
this is followed by regression of the
nodule earlier than occurs in HeLa
tumour nodules in normal mice. In
female mice HeLa tumour nodule growth
is also limited to a shorter period than
that of the controls. If male mice,
however, are treated with androgen alone
there is potentiation of the HeLa tumour
nodule growth, followed by sustained
growth beyond that of the controls.
It is difficult to explain this difference
in tumour survival in response to andro-
gen on the basis of the observed changes
in the total lymphocyte count alone,
unless there has been an associated
change in the cell mediated response.
If a change in cell mediated immunity
has occurred, why androgen should be
able to both depress and to stimulate
this in male mice, and why there is this
(lifference in response between males and
females, cannot be explained at present.
In all these investigations a non-
hormone dependent tumour has been
used and yet it has been possible to
influence the growth by changing the
hormonal status of the mice. Hormone
administration has been used with bene-
ficial results in clinical medicine to treat
some human tumours thought not to be
highly hormone dependent (Drug Ther.
Bull., 1970; Wagle and Murphy, 1970)
and has been used with considerable
success against hormone responsive tu-
mours such as breast and prostate (Hay-
ward, 1970).
Although it is dangerous to extra-
polate results obtained in mice with
transplanted tumours (in which grossly
unphysiological doses of hormones were
used) to the human situation (in which
unphysiological doses of hormones are
also used), it is suggested that the suc-
cesses observed in the use of hormone
manipulation as a treatment for cancer
in man may not be due entirely to a
change in the in vivo hormonal status,
but to a concurrent and perhaps comple-
mentary change in the immune response.
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